A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the world workshop on oral …
A Wolff, RK Joshi, J Ekström, D Aframian… - Drugs in R&d, 2017 - Springer
Background Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation
of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of …
of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of …
Reconsidering anhedonia in depression: lessons from translational neuroscience
MT Treadway, DH Zald - Neuroscience & Biobehavioral Reviews, 2011 - Elsevier
Anhedonia is a core symptom of major depressive disorder (MDD), the neurobiological
mechanisms of which remain poorly understood. Despite decades of speculation regarding …
mechanisms of which remain poorly understood. Despite decades of speculation regarding …
Depression in late life: review and commentary
DG Blazer - The journals of gerontology series A: Biological …, 2003 - academic.oup.com
Depression is perhaps the most frequent cause of emotional suffering in later life and
significantly decreases quality of life in older adults. In recent years, the literature on late-life …
significantly decreases quality of life in older adults. In recent years, the literature on late-life …
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Background Conventional meta-analyses have shown inconsistent results for efficacy of
second-generation antidepressants. We therefore did a multiple-treatments meta-analysis …
second-generation antidepressants. We therefore did a multiple-treatments meta-analysis …
Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis
G Gartlehner, RA Hansen, LC Morgan… - Annals of internal …, 2011 - acpjournals.org
Background: Second-generation antidepressants dominate the management of major
depressive disorder (MDD), but evidence on the comparative benefits and harms of these …
depressive disorder (MDD), but evidence on the comparative benefits and harms of these …
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
This review summarizes evidence of dysregulated reward circuitry function in a range of
neurodevelopmental and psychiatric disorders and genetic syndromes. First, the …
neurodevelopmental and psychiatric disorders and genetic syndromes. First, the …
A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor
SM Stahl, JF Pradko, BR Haight, JG Modell… - … care companion to …, 2004 - psychiatrist.com
Background: The neurochemical and biological effects of antidepressant medications have
become better defined over the last decade. When the antidepressant bupropion was …
become better defined over the last decade. When the antidepressant bupropion was …
Drug effects on salivary glands: dry mouth
C Scully Cbe - Oral diseases, 2003 - Wiley Online Library
Objective: To identify drugs associated with the complaint of dry mouth. Materials and
Methods: MEDLINE was searched for papers 1980–2002 using keywords, oral, mouth …
Methods: MEDLINE was searched for papers 1980–2002 using keywords, oral, mouth …
Depression in the elderly
WD Taylor - New England journal of medicine, 2014 - Mass Medical Soc
Key Clinical Points Depression in the Elderly Late-life depression (occurring in persons 60
years of age or older) is common and is often associated with coexisting medical illness …
years of age or older) is common and is often associated with coexisting medical illness …
Weight gain and antidepressants
M Fava - Journal of Clinical Psychiatry, 2000 - psychiatrist.com
Weight gain during antidepressant treatment can be either a sign of improvement in patients
who have weight loss as a symptom of depression or a residual symptom in patients who …
who have weight loss as a symptom of depression or a residual symptom in patients who …